Comparative analysis of liver cancer burden trends in China and worldwide between 1990 and 2021
The liver cancer burden in China has declined over the past three decades, with a more significant decrease in China than globally. However, China still faces a higher burden compared to the global average. The earlier peak in liver cancer burden among Chinese males suggests the need for targeted prevention and control measures, especially in light of the impact of risk factors like hepatitis B and C, alcohol consumption, drug abuse, obesity, diabetes and tobacco use. Globally, liver cancer remains a significant public health challenge with rising incidence and prevalence rates, emphasizing the need for a comprehensive global approach to liver cancer prevention.
Authors
- Haike Lei (ORCID: https://orcid.org/0000-0003-0284-2052)
- Qianjie Xu (ORCID: https://orcid.org/0000-0002-3195-8372)
- Tao Wang (ORCID: https://orcid.org/0000-0001-6402-5571)
- Xiaosheng Li (ORCID: https://orcid.org/0009-0007-4507-2488)
- Xiaodong Zheng (ORCID: https://orcid.org/0000-0002-7768-5269)
- Chun‐Rong Chen
- Yuliang Yuan (ORCID: https://orcid.org/0000-0003-3817-2687)
- Zuhai Hu
Institutions
- Chongqing Public Health Medical Center (CN)
- Chongqing Cancer Hospital (CN)
- Chongqing Medical and Pharmaceutical College (CN)
- Chongqing Three Gorges University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2025-05-23
- DOI
- https://doi.org/10.3389/fpubh.2025.1513210
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- University of Washington
- Institute for Health Metrics and Evaluation